Related Experiment Video
Updated: May 11, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
Functional and molecular imaging of localized and recurrent prostate cancer
Kinzya Grant1, Maria L Lindenberg, Haytham Shebel
1Molecular Imaging Program, National Cancer Institute, NIH, Bethesda, MD 20892-1088, USA.
Abstract:
Prostate cancer is the most common malignancy among American men. Imaging of localized and recurrent prostate cancer is challenging since conventional imaging techniques are limited. New imaging techniques such as multiparametric MRI and PET with targeted tracers have been investigated extensively in the last decade. As a result, the role of novel imaging techniques for the detection of localized and recurrent prostate cancer has recently expanded. In this review, novel functional and molecular imaging techniques used in the management of localized and recurrent prostate cancer are discussed.

